(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OLATEC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OLATEC

ST13

US500000088150366

Class

5

Filing

88150366

Registration

5830249

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

11/05/2025

Trademark type

Word

Nice classes

5

Filing date

10/10/2018

Registration date

08/06/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/04/2025

Last transaction

11/05/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/10/2013

First use in commerce

05/10/2013

Drawing code

4

Owner type

16

Owner location

New York, NY

Examiner

BEN,LINDSEY HEATHER

Current location

Historical data usage

Holders and representatives

Holders

Olatec Therapeutics LLC

Representatives

Viola T. Kung PERKINS COIE LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Analgesics; Anti-inflammatories; Anti-inflammatory pharmaceuticals; Anti-inflammatory preparations and chemical compounds; Pharmaceutical preparations and products for the prevention of diseasesinflammatory disorders and conditions; Pharmaceutical preparations and products for the prevention of diseasespain in humans and animals; Pharmaceutical preparations and substances for the treatment of inflammatory disorders and diseases; Therapeutic pharmaceutical preparations and substances for the treatment of pain and inflammation; Pharmaceutical preparations and products for medical purposes for treating inflammatory disorders and conditions in humans and animals

Publications

History of USPTO decisions and trademark events.

30 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/04/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/04/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/03/2025

E815

TEAS SECTION 8 & 15 RECEIVED

07/11/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/06/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/02/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/01/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/28/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/27/2019

EX1G

SOU EXTENSION 1 GRANTED

06/27/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/27/2019

IUAF

USE AMENDMENT FILED

06/24/2019

EXT1

SOU EXTENSION 1 FILED

06/24/2019

EEXT

SOU TEAS EXTENSION RECEIVED

06/24/2019

EISU

TEAS STATEMENT OF USE RECEIVED

06/24/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/14/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/19/2019

PUBO

PUBLISHED FOR OPPOSITION

03/19/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/27/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/13/2019

ALIE

ASSIGNED TO LIE

02/11/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/25/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

01/25/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/25/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

01/25/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/25/2019

DOCK

ASSIGNED TO EXAMINER

01/21/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/21/2018

NWAP

NEW APPLICATION ENTERED

10/13/2018

Continuous trademark protection

Get notified about every new filing that threatens OLATEC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.